Search hospitals
>
Texas
>
San Antonio
Methodist Children's Hospital of South Texas
Claim this profile
San Antonio, Texas 78229
Global Leader in Cancer
Global Leader in Brain Tumor
Conducts research for Acute Lymphoblastic Leukemia
Conducts research for Neuroblastoma
Conducts research for Lymphoma
185 reported clinical trials
2 medical researchers
Summary
Methodist Children's Hospital of South Texas is a medical facility located in San Antonio, Texas. This center is recognized for care of Cancer, Brain Tumor, Acute Lymphoblastic Leukemia, Neuroblastoma, Lymphoma and other specialties. Methodist Children's Hospital of South Texas is involved with conducting 185 clinical trials across 328 conditions. There are 2 research doctors associated with this hospital, such as Jose M. Esquilin and Vinod K. Gidvani-Diaz.
Area of expertise
Cancer
Methodist Children's Hospital of South Texas has run 47 trials for Cancer. Some of their research focus areas include:
Brain Tumor
Methodist Children's Hospital of South Texas has run 35 trials for Brain Tumor. Some of their research focus areas include:
Top PIs
Jose M. Esquilin
Methodist Children's Hospital of South Texas
6 years of reported clinical research
Vinod K. Gidvani-Diaz
Methodist Children's Hospital of South Texas
8 years of reported clinical research
Clinical Trials running at Methodist Children's Hospital of South Texas
Testicular cancer
Leukemia
Wilms Tumor
Neuroblastoma
Burkitt Lymphoma
Acute Lymphoblastic Leukemia
Ovarian Carcinoma
Ovarian Tumors
Testicular Carcinoma
Ovarian Choriocarcinoma
Chemotherapy
for Cancer
This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is removed. When the germ cell tumor has spread outside of the organ in which it developed, it is considered metastatic. Chemotherapy drugs, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. The trial studies whether carboplatin or cisplatin is the preferred chemotherapy to use in treating metastatic standard risk germ cell tumors.
Recruiting
2 awards
Phase 3
26 criteria
Chemotherapy + Radiation Therapy
for Brain Cancer
This phase II trial studies the best approach to combine chemotherapy and radiation therapy (RT) based on the patient's response to induction chemotherapy in patients with non-germinomatous germ cell tumors (NGGCT) that have not spread to other parts of the brain or body (localized). This study has 2 goals: 1) optimizing radiation for patients who respond well to induction chemotherapy to diminish spinal cord relapses, 2) utilizing higher dose chemotherapy followed by conventional RT in patients who did not respond to induction chemotherapy. Chemotherapy drugs, such as carboplatin, etoposide, ifosfamide, and thiotepa, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high energy x-rays or high-energy protons to kill tumor cells and shrink tumors. Studies have shown that patients with newly-diagnosed localized NGGCT, whose disease responds well to chemotherapy before receiving radiation therapy, are more likely to be free of the disease for a longer time than are patients for whom the chemotherapy does not efficiently eliminate or reduce the size of the tumor. The purpose of this study is to see how well the tumors respond to induction chemotherapy to decide what treatment to give next. Some patients will be given RT to the spine and a portion of the brain. Others will be given high dose chemotherapy and a stem cell transplant before RT to the whole brain and spine. Giving treatment based on the response to induction chemotherapy may lower the side effects of radiation in some patients and adjust the therapy to a more efficient one for other patients with localized NGGCT.
Recruiting
1 award
Phase 2
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Methodist Children's Hospital of South Texas?
Methodist Children's Hospital of South Texas is a medical facility located in San Antonio, Texas. This center is recognized for care of Cancer, Brain Tumor, Acute Lymphoblastic Leukemia, Neuroblastoma, Lymphoma and other specialties. Methodist Children's Hospital of South Texas is involved with conducting 185 clinical trials across 328 conditions. There are 2 research doctors associated with this hospital, such as Jose M. Esquilin and Vinod K. Gidvani-Diaz.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.